Effects of linagliptin on diabetic nephropathy in CKD patients

Effects of linagliptin on diabetic nephropathy in CKD patients - Effects of linagliptin on diabetic nephropathy in CKD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010952

Enrollment

100

Registered

2013-06-13

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with diabetic nephropathy

Interventions

linagliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetic nephropathy

Exclusion criteria

Exclusion criteria: 1) diabetic ketoacidosis 2) severe infection 3) pregnancy 4) CHF, AKI 5) severe liver dysfunction

Design outcomes

Primary

Measure	Time frame
improvement of albuminuria	—

Secondary

Measure	Time frame
improvement of GLP-1 activity, AGEs and glucose control	—

Countries

Japan

Contacts

Public ContactKei Fukami

Kurume University School of Medicine Division of Nephrology, Department of Medicine,

fukami@med.kurume-u.ac.jp0942-35-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026